Infectious Disease
ACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common Allergies
Pfizer COVID-19 vaccine should not be administered to individuals with a known history of severe reaction to polyethylene glycol
High-Income Countries Have Secured COVID-19 Vaccine Supplies
Up to 40 percent of vaccine courses from manufacturers might remain for low- and middle-income countries by end of 2021
Alaska HCW First in U.S. to Have Allergic Reaction to COVID-19 Vaccine
Worker felt flushed within 10 minutes of receiving vaccine, followed by shortness of breath and elevated heart rate
For Seniors, Functional Decline After Flu Hospitalization May Be Long-Lasting
Findings stress importance of prevention, especially for the flu, in the elderly
Advisory Committee Votes to Recommend EUA for Moderna Vaccine
Could become the second COVID-19 vaccine in a week to receive emergency use authorization
71 Percent in U.S. Report That They Would Get COVID-19 Vaccine
Twenty-seven percent of Americans remain vaccine-hesitant, with variation across groups, up to 42 percent among Republicans
Most Health Facilities Still Using Crisis Standards for Protective Equipment
Furthermore, infection control specialists seeing increases in health care-associated infections since start of pandemic
WHO Team Seeks to Pinpoint Source of COVID-19
Most experts believe SARS-CoV-2 originated in animals in China, probably bats
One in Five Patients Hospitalized With COVID-19 Dies
Statins, angiotensin-converting enzyme inhibitors, and calcium channel blockers tied to lower risk for death
Americans Showing Hesitancy Toward COVID-19 Testing
Majority of adults believing they need a COVID-19 test delay or avoid testing, most often due to exposure fear
